BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31794334)

  • 1. Reducing Disparities in Receipt of Genetic Counseling for Underserved Women at Risk of Hereditary Breast and Ovarian Cancer.
    Sutton AL; Hurtado-de-Mendoza A; Quillin J; Rubinsak L; Temkin SM; Gal T; Sheppard VB
    J Womens Health (Larchmt); 2020 Aug; 29(8):1131-1135. PubMed ID: 31794334
    [No Abstract]   [Full Text] [Related]  

  • 2. Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
    Cragun D; Weidner A; Lewis C; Bonner D; Kim J; Vadaparampil ST; Pal T
    Cancer; 2017 Jul; 123(13):2497-2505. PubMed ID: 28182268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
    Cragun D; Bonner D; Kim J; Akbari MR; Narod SA; Gomez-Fuego A; Garcia JD; Vadaparampil ST; Pal T
    Breast Cancer Res Treat; 2015 May; 151(1):169-76. PubMed ID: 25868867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.
    Hoskins KF; Tejeda S; Vijayasiri G; Chukwudozie IB; Remo MH; Shah HA; Abraham IE; Balay LE; Maga TK; Searles ER; Korah VJ; Biggers A; Stolley MR; Warnecke RB
    Cancer; 2018 Sep; 124(18):3733-3741. PubMed ID: 30320429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City.
    Sussner KM; Jandorf L; Thompson HS; Valdimarsdottir HB
    Psychooncology; 2013 Jul; 22(7):1594-604. PubMed ID: 22987526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking the dissemination of a culturally targeted brochure to promote awareness of hereditary breast and ovarian cancer among Black women.
    Scherr CL; Bomboka L; Nelson A; Pal T; Vadaparampil ST
    Patient Educ Couns; 2017 May; 100(5):805-811. PubMed ID: 27866793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and facilitators to genetic testing for breast and ovarian cancer amongst Black African women in Luton (UK).
    Kabeya V; Puthussery S; Furmanski A
    J Genet Couns; 2024 Apr; 33(2):425-444. PubMed ID: 37403830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.
    Kinney AY; Steffen LE; Brumbach BH; Kohlmann W; Du R; Lee JH; Gammon A; Butler K; Buys SS; Stroup AM; Campo RA; Flores KG; Mandelblatt JS; Schwartz MD
    J Clin Oncol; 2016 Aug; 34(24):2914-24. PubMed ID: 27325848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.
    Kinney AY; Howell R; Ruckman R; McDougall JA; Boyce TW; Vicuña B; Lee JH; Guest DD; Rycroft R; Valverde PA; Gallegos KM; Meisner A; Wiggins CL; Stroup A; Paddock LE; Walters ST
    Contemp Clin Trials; 2018 Oct; 73():123-135. PubMed ID: 30236776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research.
    Wheeler SB; Reeder-Hayes KE; Carey LA
    Oncologist; 2013; 18(9):986-93. PubMed ID: 23939284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial Disparities in Accessing Care along the Continuum of Cancer Genetic Service Delivery.
    Wagner IM; Xuan Z; Lu H; Wang C
    Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):55-62. PubMed ID: 37819271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of a culturally sensitive intervention to promote genetic counseling for breast cancer risk.
    Henderson V; Madrigal JM; Kendall LC; Parekh P; Newsome J; Chukwudozie IB; Comer-Hagans L; Coffey V; Grumbach G; Spencer S; Rodgers C; Kaur R; Balay L; Maga T; Ramamonjiarivelo Z; Balthazar C; Winn R; Watson K; Odoms-Young A; Hoskins KF
    BMC Health Serv Res; 2022 Jun; 22(1):826. PubMed ID: 35752812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling.
    Peshkin BN; Kelly S; Nusbaum RH; Similuk M; DeMarco TA; Hooker GW; Valdimarsdottir HB; Forman AD; Joines JR; Davis C; McCormick SR; McKinnon W; Graves KD; Isaacs C; Garber J; Wood M; Jandorf L; Schwartz MD
    J Genet Couns; 2016 Jun; 25(3):472-82. PubMed ID: 26455498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of racial disparities in ovarian cancer and clinical trials.
    Ali M; Tewari KS
    Curr Opin Obstet Gynecol; 2024 Feb; 36(1):23-27. PubMed ID: 38170549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA genetic counseling among at-risk Latinas in New York City: new beliefs shape new generation.
    Sussner KM; Edwards T; Villagra C; Rodriguez MC; Thompson HS; Jandorf L; Valdimarsdottir HB
    J Genet Couns; 2015 Feb; 24(1):134-48. PubMed ID: 25120034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of the "BRCA Quality Improvement Dissemination Program": An initiative to improve patient receipt of cancer genetics services at five health systems.
    Bednar EM; Chen M; Walsh MT; Eppolito AL; Klein MH; Teed K; Hodge B; Hunter J; Chao HG; Davis D; Serchion W; Yobbi C; Krukenberg R; Jenkinson SB; Moore JJ; Garcia C; Gonzalez F; Murray T; Nielsen LD; Ho B; Haas M; Greenzweig SB; Anderson A; Johnson C; Morman NA; Bowdish E; Wise E; Cooper JN; Russ PK; Tondo-Steele K; de Gracia BF; Levin B; Mattie K; Zarnawski K; Kalasinski M; Stone J; O'Brien C; Bream A; Kennedy AM; Paul RA; Bilbao M; Romero M; Carr RL; Siettmann JM; Vercruyssen AK; Leon K; Arun BK; Grainger AV; Warshal DP; Bowman E; Goedde TA; Halaharvi D; Rath K; Grana G; Mina L; Lu KH
    Gynecol Oncol; 2023 May; 172():106-114. PubMed ID: 37004303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow.
    Kinney AY; Walters ST; Lin Y; Lu SE; Kim A; Ani J; Heidt E; Le Compte CJG; O'Malley D; Stroup A; Paddock LE; Grumet S; Boyce TW; Toppmeyer DL; McDougall JA
    J Clin Oncol; 2023 May; 41(15):2767-2778. PubMed ID: 36787512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Disparities in Breast Cancer Genetic Testing May be Mitigated by Counseling.
    Siegel JB; Bertolino M; Mukherjee R; Meeder K; Hughes KS; Abbott AM
    Ann Surg Oncol; 2024 May; ():. PubMed ID: 38811498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migrant breast cancer patients and their participation in genetic counseling: results from a registry-based study.
    Baars JE; van Dulmen AM; Velthuizen ME; Theunissen EB; Vrouenraets BC; Kimmings AN; van Dalen T; van Ooijen B; Witkamp AJ; van der Aa MA; Ausems MG
    Fam Cancer; 2016 Apr; 15(2):163-71. PubMed ID: 26833044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status.
    Van Alsten SC; Dunn MR; Hamilton AM; Ivory JM; Gao X; Kirk EL; Nsonwu-Farley JS; Carey LA; Abdou Y; Reeder-Hayes KE; Roberson ML; Wheeler SB; Emerson MA; Hyslop T; Troester MA
    Cancer Epidemiol Biomarkers Prev; 2024 May; 33(5):654-661. PubMed ID: 38270534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.